2018 Korea CPHI, Merck meeting

Sep 03, 2018
2018 Korea CPHI, we have successfully meeting with Bayer, Merck, MITSUBISHI pharma.

2018 B28, welcome to visit.

Korea customer have big interesting in our custom synthesis ability. Below reaction:



Alkylation, Amidation,
Bromination, Chiral
Resolution,Condensatio
n, Cyanoethlyation,
Dehydrohalogenation,
Diazotization, Enzymatic
Custom Synthesis,
Esterification,
Ethoxylation,
Fluorination,
Hydrogenation,
Nitration,
Oxidation,
Organometallic Custom
Synthesis, Phosgenation, Phosphation, Polymerization,
Quaternization, Reductive Amination, Sulfonation
已经到最底了